154 related articles for article (PubMed ID: 4269971)
1. Dopamine and noradrenaline transport into subcellular vesicles of the striatum.
Philippu A; Beyer J
Naunyn Schmiedebergs Arch Pharmacol; 1973; 278(4):387-402. PubMed ID: 4269971
[No Abstract] [Full Text] [Related]
2. Turning behavior of mice with unilateral 6-hydroxydopamine lesions in the striatum: effects of apomorphine, L-DOPA, amanthadine, amphetamine and other psychomotor stimulants.
Von Voigtlander PF; Moore KE
Neuropharmacology; 1973 May; 12(5):451-62. PubMed ID: 4145343
[No Abstract] [Full Text] [Related]
3. Dopamine and norepinephrine uptake by rat brain synaptosomes: relative inhibitory potencies of 1- and d-amphetamine and amantadine.
Thornburg JE; Moore KE
Res Commun Chem Pathol Pharmacol; 1973 Jan; 5(1):81-9. PubMed ID: 4686111
[No Abstract] [Full Text] [Related]
4. Uptake of (3H)-catecholamines by homogenates of rat corpus striatum and cerebral cortex: effects of amphetamine analogues.
Harris JE; Baldessarini RJ
Neuropharmacology; 1973 Jul; 12(7):669-79. PubMed ID: 4730376
[No Abstract] [Full Text] [Related]
5. In vivo effects of benztropine and nomifensine on dopamine and noradrenaline terminals in rat brain.
Broch OJ
Eur J Pharmacol; 1979 Oct; 58(4):419-24. PubMed ID: 510376
[No Abstract] [Full Text] [Related]
6. Increased dopamine concentration in the striatum in the mouse by FLA-63, a dopamine- -hydroxylase inhibitor.
Svensson TH
J Pharm Pharmacol; 1973 Jan; 25(1):73-5. PubMed ID: 4146204
[No Abstract] [Full Text] [Related]
7. The effect of amantadine on radiolabeled biogenic amines in the rat brain.
Symchowicz S; Korduba CA; Veals J
Eur J Pharmacol; 1973 Feb; 21(2):155-60. PubMed ID: 4696098
[No Abstract] [Full Text] [Related]
8. Inhibition of the uptake of tritiated catecholamines by antidepressant and related agents.
Ross SB; Renyi AL
Eur J Pharmacol; 1967 Dec; 2(3):181-6. PubMed ID: 5591516
[No Abstract] [Full Text] [Related]
9. Comparison of the effects of the isomers of amphetamine, methylphenidate and deoxypipradrol on the uptake of l-[3H]norepinephrine and [3H]dopamine by synaptic vesicles from rat whole brain, striatum and hypothalamus.
Ferris RM; Tang FL
J Pharmacol Exp Ther; 1979 Sep; 210(3):422-8. PubMed ID: 39160
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of the uptake of 5-hydroxytryptamine, noradrenaline and dopamine into rat brain homogenates by various hydroxylated tryptamines.
Horn AS; Baumgarten HG; Schlosserberger HG
J Neurochem; 1973 Jul; 21(1):233-6. PubMed ID: 4720899
[No Abstract] [Full Text] [Related]
11. Effect of brain lesions and chlorpromazine on accumulation and disappearance of catecholamines formed in vivo from 14 C-tyrosine.
Nybäck H
Acta Physiol Scand; 1972 Jan; 84(1):54-64. PubMed ID: 5029384
[No Abstract] [Full Text] [Related]
12. Effects of amantadine on uptake and release of dopamine by a particulate fraction of rat basal ganglia.
Heimans RL; Rand MJ; Fennessy MR
J Pharm Pharmacol; 1972 Nov; 24(11):875-9. PubMed ID: 4405650
[No Abstract] [Full Text] [Related]
13. Amantadine and catecholamine uptake.
Herblin WF
Biochem Pharmacol; 1972 Jul; 21(14):1993-5. PubMed ID: 4649347
[No Abstract] [Full Text] [Related]
14. Dopamine turnover in the rat corpus striatum: in vivo and in vitro studies on the action of amantadine.
Vaatstra WJ; Eigeman L
Eur J Pharmacol; 1974 Feb; 25(2):185-90. PubMed ID: 4435022
[No Abstract] [Full Text] [Related]
15. Effect of gamma-hydroxybutyrate on dopamine and dopamine metabolites in the rat striatum.
Walters JR; Roth RH
Biochem Pharmacol; 1972 Aug; 21(15):2111-21. PubMed ID: 4645883
[No Abstract] [Full Text] [Related]
16. Effect of drugs on the uptake of noradrenaline by isolated hypothalamic vesicles.
Philippu A; Becke H; Burger A
Eur J Pharmacol; 1969 May; 6(2):96-101. PubMed ID: 4240358
[No Abstract] [Full Text] [Related]
17. Drugs affecting monoamines in the basal ganglia.
Bartholini G; Pletscher A
Adv Biochem Psychopharmacol; 1972; 6():135-48. PubMed ID: 4560163
[No Abstract] [Full Text] [Related]
18. The influence of 1-hydroxy-3-amino pyrrolidinone-2 (HA-966) on dopamine metabolism in the corpus striatum.
Hillen FC; Noach EL
Eur J Pharmacol; 1971 Oct; 16(2):222-4. PubMed ID: 5161260
[No Abstract] [Full Text] [Related]
19. L-dopa in Parkinsonism. A possible mechanism of action.
Ng LK; Chase TN; Colburn RW; Kopin IJ
Neurology; 1972 Jul; 22(7):688-96. PubMed ID: 4673250
[No Abstract] [Full Text] [Related]
20. Amphetamine: differentiation by d and l isomers of behavior involving brain norepinephrine or dopamine.
Taylor KM; Snyder SH
Science; 1970 Jun; 168(3938):1487-9. PubMed ID: 5463064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
